HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Almay Clear Complexion Expands Range To Include Makeup, Concealer

This article was originally published in The Rose Sheet

Executive Summary

Almay will support the launch of new Clear Complexion Blemish Healing Makeup and Concealer with print ads breaking in May books, as well as a TV campaign, the Revlon division said

You may also be interested in...



ALMAY ADDING FASHION IMAGE TO BRAND'S HYPO-ALLERGENIC POSITIONING

ALMAY ADDING FASHION IMAGE TO BRAND'S HYPO-ALLERGENIC POSITIONING by offering new products and line extensions in an expanded shade range as well as new packaging beginning in the spring. "All About Color," a promotional campaign breaking with the launches, will present the line's new image while maintaining Almay's traditional benefits of being "gentle, hypo-allergenic and safe." Almay also is updating its blue-and-white packaging by adding silver graphics during 1995.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel